RetinalGenix Technologies (RTGN) Change in Accured Expenses (2021 - 2026)
RetinalGenix Technologies (RTGN) posted Change in Accured Expenses of $960.0 for Q1 2026, little changed sequentially from $960.0 in Q4 2025, and little changed YoY from $960.0 in Q1 2025.
RetinalGenix Technologies (RTGN) Change in Accured Expenses (2021 - 2026) Analysis & Trends
RetinalGenix Technologies has reported Change in Accured Expenses for 6 years, with the latest figure at $960.0 in Q1 2026.
- Quarterly Change in Accured Expenses changed 0.0% year-over-year to $960.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3840.0 (up 105.2% YoY) and the FY2025 annual result came in at $3840.0, changed 0.0% from the prior year.
- Change in Accured Expenses steadied at $960.0 in Q1 2026 per RTGN's latest filing, from $960.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $112485.0 in Q3 2022 and troughed at -$110265.0 in Q4 2022.
- A 5-year average of $1036.5 and a median of $960.0 in 2023 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses soared 8086.25% in 2024, then sank 9654.38% in 2025.
- Over 5 years, Change in Accured Expenses stood at -$110265.0 in 2022, then jumped by 100.87% to $960.0 in 2023, then changed by 0.0% to $960.0 in 2024, then changed by 0.0% to $960.0 in 2025, then changed by 0.0% to $960.0 in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered $960.0, $960.0, and -$91722.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.60 Bn | 194.00 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.14 Bn | 123.66 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.89 Bn | 109.67 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 73.11 Bn | 72.57 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 52.03 Bn | 47.78 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.31 Bn | 32.36 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 4.80 Mn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | 104,757.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 960.00 |
| Mar 31, 2026 | 960.00 |
| Dec 31, 2025 | 960.00 |
| Dec 31, 2025 | 960.00 |
| Sep 30, 2025 | -91,722.00 |
| Sep 30, 2025 | -91,722.00 |
| Jun 30, 2025 | 93,642.00 |
| Jun 30, 2025 | 93,642.00 |
| Mar 31, 2025 | 960.00 |
| Mar 31, 2025 | 960.00 |
| Dec 31, 2024 | 960.00 |
| Dec 31, 2024 | 960.00 |
| Sep 30, 2024 | 960.00 |
| Sep 30, 2024 | 960.00 |
| Jun 30, 2024 | -76,668.00 |
| Jun 30, 2024 | -76,668.00 |
| Mar 31, 2024 | 78,588.00 |
| Mar 31, 2024 | 78,588.00 |
| Dec 31, 2023 | 960.00 |
| Dec 31, 2023 | 960.00 |